Yu Junpu, Luo Fanhui, Zhang Yiwen, Yang Jingli, Yu Shuxia, Li Nan, Yang Aimin, Ma Li, Li Jinsheng
School of Public Health, Lanzhou University, Lanzhou, Gansu, China.
Department of Medical Administration, Gansu Provincial Maternity and Child-care Hospital, Lanzhou, Gansu, China.
Front Endocrinol (Lausanne). 2025 Aug 11;16:1429048. doi: 10.3389/fendo.2025.1429048. eCollection 2025.
To evaluate the spatial-temporal changes in the incidence of type 2 diabetes related chronic kidney disease (CKD-T2DM) from 1990 to 2019, categorized by age and sex in 21 regions with different socio-demographic indexes (SDI), and to predict the incidence rate between 2020 and 2030.
Data on the burden of CKD-T2DM were obtained from the Global Burden of Disease Study 2019. Age-standardized incidence rates (ASIR) were estimated by sex, age, region, SDI, and specifically in China. The trends of ASIR were assessed using Joinpoint model to calculate the average annual percentage changes (AAPCs) and their 95% confidence intervals. Prediction was conducted using the Bayesian age-period-cohort (BAPC) model.
In 2019, the ASIR of global CKD-T2DM increased with age in both sexes, and was highest in the older 75 age group. The ASIR of CKD-T2DM in males was higher than those in females. Overall, the global ASIR of CKD-T2DM increased from 1990 to 2019 in both sexes and all age groups. The most significant increase was observed in the 15-49 age group [males: AAPC=1.42, 95%CI:(1.35-1.49); females: AAPC=1.18,95%CI:(1.13-1.23)]. Besides, the upward trends in ASIR of CKD-T2DM were observed in most SDI regions and GBD regions. The changing trends in ASIR of CKD-T2DM in China were similar to the global trends. Finally, the predicted ASIR was also found to be increased globally and also in China in both sex from 2020 to 2030.
The global CKD-T2DM incidence rates increased from 1990 to 2019 in both sexes, most regions and in China., and also increased globally between 2020 and 2030. Therefore, it is important to input more medical resources and establish prevention strategies for the increasing trends of CKD-T2DM.
评估1990年至2019年2型糖尿病相关慢性肾脏病(CKD-T2DM)发病率的时空变化,按年龄和性别在21个具有不同社会人口学指数(SDI)的地区进行分类,并预测2020年至2030年的发病率。
CKD-T2DM负担数据来自《2019年全球疾病负担研究》。按性别、年龄、地区、SDI,特别是在中国,估计年龄标准化发病率(ASIR)。使用Joinpoint模型评估ASIR趋势,以计算年均百分比变化(AAPC)及其95%置信区间。使用贝叶斯年龄-时期-队列(BAPC)模型进行预测。
2019年,全球CKD-T2DM的ASIR在两性中均随年龄增加,在75岁及以上年龄组中最高。男性CKD-T2DM的ASIR高于女性。总体而言,1990年至2019年,全球CKD-T2DM的ASIR在两性和所有年龄组中均有所增加。在15-49岁年龄组中观察到最显著的增加[男性:AAPC=1.42,95%CI:(1.35-1.49);女性:AAPC=1.18,95%CI:(1.13-1.23)]。此外,在大多数SDI地区和全球疾病负担(GBD)地区观察到CKD-T2DM的ASIR呈上升趋势。中国CKD-T2DM的ASIR变化趋势与全球趋势相似。最后,还发现从2020年到2030年,全球和中国两性的预测ASIR均会增加。
1990年至2019年,全球CKD-T2DM发病率在两性、大多数地区及中国均有所增加,2020年至2030年全球也呈上升趋势。因此,为应对CKD-T2DM不断增加的趋势投入更多医疗资源并制定预防策略很重要。